• Michael Good
• ANU College of Medicine and Health Sciences

GO TO

13 November 2009Learning how to harness the power of the immune system to combat infectious killers has been one of the most dramatic developments in the history of medicine.  Eradication of smallpox and the near elimination of polio serve to remind us that the destiny of disease can be written by human ingenuity.  These and other great feats continue to inspire us all as we strive to combat major infectious killers of the 21st Century.  Success rarely comes easily and we are enormously challenged by various viruses, bacteria and parasites that collectively cause several million deaths per year.  A common thread of the resistance to immunity and vaccine development is the uncanny ability to escape immune attack by altering coat proteins and to further subvert the immune system.  A major strategy of vaccine development is to identify a non variable region of the organism that can be an immune Achilles heel for the germ.  Another approach is to combine the most common immune determinants ('epitopes') of different strains of a particular organism into a single vaccine in the hope that the vaccine will prevent infection with the majority of strains. 

Developing effective vaccines requires not only scientific nous but an understanding of the daily challenges of those peoples whose lives are affected.  It is critical that they are centrally involved in the research program and understand both the hope and the limitations of the various approaches.  If not, it is unlikely they will persist in a collaborative program that may take many decades to realise ultimate success.  Malaria vaccine research, as an example, has provided a roller coaster emotional ride over the last 25 years for both researchers and those living in endemic countries. While this can be disconcerting it is critical that we continue for malaria and the many other challenges that we face.  The consequences of not doing so are too awful to contemplate.

This was the World Day of Immunology 2009 Public Lecture. Presented by The John Curtin School of Medical Research and Australasian Society for Immunology.